About this podcast
Scientific innovation happens every day and has the power to create lasting change in the world. However, change only happens when that knowledge is applied to a real-world problem. There are a lot of daunting problems that face us, many of which require audacious and ambitious solutions. What prevents scientific leaders from delivering our most-needed solutions? What about a great story compels us to solve our most demanding challenges?
Explore the importance of storytelling as a leadership tool to power scientific innovation and drive transformative change. Join two entrepreneurs – Dani Stoltzfus and Will Riedl – as we interview innovators, trailblazers, and rulebreakers who seek to transform the world through scientific advancement.
Powered by Mighty Spark Communications.
Episodes
The newest 20 of 33 episodes
- Ep. 33 How Lytix Biopharma Reimagined Host-Defense Peptides as Oncolytic Molecules for Immunotherapy · 30 min · Season 1 Episode 33In this episode of Spark Time!, we speak with Øystein Rekdal, co-founder and CEO of Lytix Biopharma, about how the company reimagined host-defense peptides as a new class of…
- Ep. 32 Alzheimer's Breakthrough? Recall Thinks Restoration Is Possible · 55 min · Season 1 Episode 32What if an Alzheimer's therapy did not just slow decline, but restored memory and physical health back to baseline? In this episode of Spark Time, we sit down with Dan Salain…
- Ep. 31 Zero G, Crystals and Keytruda: Space MD Builds the New Frontier of Drug Design · 56 min · Season 1 Episode 31In this episode, we have a, high-energy conversation with Molly Mulligan and Ken Savin from Space MD about how space-made crystals are changing drug development on Earth. Their…
- Ep. 30 The Tiny Cargo Company's Milk Exosomes Could Shape the Future of Oral GLP-1 Delivery · 1 h 6 minWe talk with Alan Gourdie and Spencer Marsh from The Tiny Cargo Company, the team commercializing one of nature's most elegant delivery systems, milk-derived exosomes. We dig…
- Ep. 29 Christian Kersten & Marte Cameron: From Serendipitous Discovery to a New Era in Chronic Pain Treatment · 43 minNeuropathic pain affects nearly 10% of the global population, yet effective treatments remain elusive. In this episode of Spark Time, we sit down with…
- Ep. 28 Aneil Mallavarapu on Building and Monetizing TechBio Platforms, Storytelling and Why Diagnostics Won't Save a System Designed to Fail · 58 min · Season 1 Episode 28In this expansive episode, Aneil Mallavarapu delivers a masterclass on what TechBio is really about and why most investors and founders are still getting it wrong. We dig into…
- Ep. 27 Burn the CRO Playbook: Ardian Latifi on Building a Sponsor-First Model · 50 min · Season 1 Episode 27Learn how flexibility, real-time control, and localized trial expertise are reshaping the future of CRO's from the man redefining it. Listen in as Ardian Latifi breaks down why…
- Ep. 26 The Australian Advantage; How Global Biotechs Are Accelerating R&D with Agilex Biolabs · 43 min · Season 1 Episode 26In this episode of Spark Time, we sit down with Steve McIntyre, CEO of Agilex Biolabs, Cameron Smith, Chief Business Development Officer, Agilex Biolabs and Mike Burfield…
- Ep. 25 Javier Tordable Saw Biotech's Blind Spot. Then Built a Company to Fix It. · 55 min · Season 1 Episode 25What does a former Google leader see when he looks at the drug discovery process? A broken system and a once-in-a-generation opportunity to rebuild it with AI. Javier Tordable…
- Ep. 24 AI vs. Clinical Trial Chaos: Maree Beare Isn't Waiting Around · 40 min · Season 1 Episode 24We sit down with Maree Beare, the visionary CEO and founder of Clinials. Maree shares her journey in transforming clinical trials through AI-driven solutions, that streamline…
- Ep. 23 Jason Foster on Scaling Indivior, Leading Ori Biotech, and Solving the Real-World Bottlenecks Holding Back Cell and Gene Therapy · 57 min · Season 1 Episode 23This week we are joined by Jason Foster, CEO of Ori Biotech to talk about the future of CGT and why scalable strategic manufacturing is in a make or break moment, his experience…
- Ep. 22 Audrey Greenberg on Strategically Enabling Cell & Gene Therapy · 39 min · Season 1 Episode 22In this episode, we sit down with Audrey Greenberg, Founder and CEO of AG Capital Advisors, to explore her journey building and scaling the Center for Breakthrough Medicines into…
- Ep. 21 Emily Fang on Authentically Understanding a Global Audience · 31 min · Season 1 Episode 21We sit down with Emily Fang, CEO of InFocus Therapeutics, to discuss her global BD career, partnerships in biotech, and the state of RNA-targeting small molecules. Emily…
- Ep. 20 Martin Brenner on Intersecting AI and Biology for Obesity · 33 min · Season 1 Episode 20Martin Brenner is the CEO of iBio, a company advancing antibody therapeutics for obesity using multiple AI engines – but the company started in a very different place. Listen to…
- Ep. 19 Kate Beebe DeVarney on Channeling Cancer Challenges into Biotech Innovation · 44 min · Season 1 Episode 19Kate Beebe Devarney is a neuroscientist and biotech executive focused on bringing relief to cancer patients through Moxie Therapeutics. Listen in as she speaks candidly about the…
- Ep. 18 Jessica Owens on the Art of the Stealth Biotech · 44 min · Season 1 Episode 18This week we're joined by Jessica Owens, co-founder and GP at Initiate Ventures, who have just announced their launch of Fund I. A co-founder of GRAIL, Jessica shares her…
- Ep. 17 John Montgomery on How Branding Unlocks Funding · 37 min · Season 1 Episode 17John Montgomery of Goodlab joins us for a lively conversation about the visual side of biotech – how a good (or bad!) brand shapes the entire organization, and what elements are…
- Ep. 16 Hugh Alsop on Spinning Out Success Across Therapeutic Landscapes · 44 min · Season 1 Episode 16Join us for a fascinating discussion with Hugh Alsop, CEO of Kinoxis Therapeutics, a spin-out of The University of Sydney. We discuss communicating hard science through emotional…
- Ep. 15 Jonathan Steckbeck on What Biotech Can Learn from Poker · 37 min · Season 1 Episode 15Jonathan Steckbeck is CEO of Peptilogics, where he is charting a path to therapeutic and commercial success in antimicrobials. Listen in as he describes how AI is impacting their…
- Ep. 14 Jeff Baker and Competitive Advantages in FDA Discussions · 52 min · Season 1 Episode 14Jeff Baker, biotech veteran and former FDA Deputy Director, describes how the ability to tell a story is a competitive advantage, even in discussions with the FDA. We also dive…







